In the Journals Plus

For type 2 diabetes, intermittent vs. continuous energy restriction yields similar glycemic improvements

July 20, 2018
Adults with type 2 diabetes and obesity randomly assigned to an intermittent fasting intervention or continuous energy restriction experienced…

FDA News

Dulaglutide label to reflect new safety, efficacy data in type 2 diabetes, CKD

July 20, 2018
Eli Lilly has updated the label for the once-weekly GLP-1 receptor agonist dulaglutide to reflect new safety and efficacy data reported for adults…

In the Journals Plus

Diabetes increases risk for all cancers by 10%

July 20, 2018
Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for…

CREDENCE trial stopped early for favorable CKD findings with canagliflozin

July 19, 2018
The steering committee behind the phase 3 CREDENCE clinical trial, evaluating the efficacy and safety of the SGLT2 inhibitor canagliflozin vs…

Meeting NewsVideo

VIDEO: Antithrombotic therapy strategies in diabetes 'rapidly evolving'

July 19, 2018
PHILADELPHIA — In this video exclusive, Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and…

In the Journals Plus

In China, regional disparities persist in prevalence of CHD, stroke in type 2 diabetes

July 18, 2018
Significant regional differences exist in the prevalence and risks for coronary heart disease and stroke among adults with type 2 diabetes in China…

In the Journals Plus

Rate of HbA1c increase influences risk for diabetic polyneuropathy

July 17, 2018
Among adults with type 2 diabetes, each 1% increase in HbA1c during 10 years increases the risk for diabetic polyneuropathy by nearly 66%, according

FDA News

FDA clears first glucose meter for critically ill patients

July 17, 2018
The FDA has granted 510(k) clearance for the first finger-stick capillary testing meter for critically ill patients with diabetes, Nova Biomedical…

In the Journals

Diabetes diagnosis leads patient’s partner to change health behaviors

July 17, 2018
The partners of people recently diagnosed with diabetes were more likely to make health-related behavioral changes even without lifestyle…

Meeting News

In emerging area of ‘diabetic lung disease,’ pioglitazone may play preventive role

July 16, 2018
PHILADELPHIA — Pulmonary arterial hypertension is a growing problem in the setting of insulin resistance and type 2 diabetes, and pioglitazone…

Meeting News

Speakers revisit role of metformin in type 2 diabetes

July 16, 2018
PHILADELPHIA — The role metformin should play as first-line therapy in patients with type 2 diabetes continues to spark debate, a discussion at…

Meeting News

Newer diabetes agents show promise for renal disease

July 16, 2018
PHILADELPHIA — Large cardiovascular outcome trials for antidiabetes agents in two drug classes have yielded potentially promising data with…

Meeting News

Experts weigh pros, cons of second-line diabetes therapies

July 16, 2018
PHILADELPHIA — Panelists at the Heart in Diabetes Clinical Education Conference presented their respective arguments for their choice of SGLT2…

Meeting News

Treatment goals, benefits in CKD, CVD may need revisiting

July 15, 2018
PHILADELPHIA — Lack of data may lead to changes in treatment goals and benefits for patients with cardiovascular disease and chronic kidney…

Meeting News

Consider patient risk when targeting BP in diabetes

July 15, 2018
PHILADELPHIA — A debate continues over the optimal target for blood pressure management in type 2 diabetes with comorbid hypertension, with…

Meeting News

Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

July 15, 2018
PHILADELPHIA — Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk…

Meeting NewsVideo

VIDEO: Focus on heart failure prevention warranted in patients with diabetes

July 15, 2018
PHILADELPHIA — In this video exclusive, Javed Butler, MD, MPH, MBA, FACC, FAHA, the Patrick A. Lehan Professor and chairman of the department…

Meeting News

Lifestyle changes necessary for mitigating cardiometabolic risk

July 15, 2018
PHILADELPHIA — Lifestyle modifications, such as adherence to a healthy diet, smoking cessation and adequate exercise, are a must to help reduce…

Meeting NewsVideo

VIDEO: Newer diabetes agents join cardiologists' arsenal

July 14, 2018
PHILADELPHIA — In this video exclusive, Darren K. McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball…

Meeting News

In diabetes with CVD, traditional risk factor modification remains top priority

July 14, 2018
PHILADELPHIA — Studies demonstrating the dual efficacy of antihyperglycemic agents on both glucose and cardiovascular disease risk should…